Liver Transplantation for Hepatocellular Carcinoma: Expanding Frontiers and Building Bridges

Howard Masuoka, Charles B. Rosen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Despite significant advances in nonsurgical treatments of hepatocellular carcinoma, these approaches rarely result in cure. Surgery remains the mainstay of curative therapy for hepatocellular carcinoma. Liver transplantation, in particular, has emerged as one of the most beneficial therapeutic modalities. Questions remain, however, regarding hepatocellular carcinoma surveillance, the choice of surgical resection versus transplantation, the role of chemotherapy, optimal selection criteria for transplantation, and the role of ablative therapies to halt tumor progression and downsize tumors exceeding transplant criteria.

Original languageEnglish (US)
Pages (from-to)385-393
Number of pages9
JournalClinics in Liver Disease
Volume15
Issue number2
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Liver Transplantation
Hepatocellular Carcinoma
Transplantation
Therapeutics
Patient Selection
Neoplasms
Transplants
Drug Therapy

Keywords

  • Cirrhosis
  • Hepatocellular carcinoma
  • Liver transplantation
  • Organ allocation

ASJC Scopus subject areas

  • Hepatology

Cite this

Liver Transplantation for Hepatocellular Carcinoma : Expanding Frontiers and Building Bridges. / Masuoka, Howard; Rosen, Charles B.

In: Clinics in Liver Disease, Vol. 15, No. 2, 05.2011, p. 385-393.

Research output: Contribution to journalArticle

@article{dcab84c9dd9748bb9bcd37c5834fc6de,
title = "Liver Transplantation for Hepatocellular Carcinoma: Expanding Frontiers and Building Bridges",
abstract = "Despite significant advances in nonsurgical treatments of hepatocellular carcinoma, these approaches rarely result in cure. Surgery remains the mainstay of curative therapy for hepatocellular carcinoma. Liver transplantation, in particular, has emerged as one of the most beneficial therapeutic modalities. Questions remain, however, regarding hepatocellular carcinoma surveillance, the choice of surgical resection versus transplantation, the role of chemotherapy, optimal selection criteria for transplantation, and the role of ablative therapies to halt tumor progression and downsize tumors exceeding transplant criteria.",
keywords = "Cirrhosis, Hepatocellular carcinoma, Liver transplantation, Organ allocation",
author = "Howard Masuoka and Rosen, {Charles B.}",
year = "2011",
month = "5",
doi = "10.1016/j.cld.2011.03.005",
language = "English (US)",
volume = "15",
pages = "385--393",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Liver Transplantation for Hepatocellular Carcinoma

T2 - Expanding Frontiers and Building Bridges

AU - Masuoka, Howard

AU - Rosen, Charles B.

PY - 2011/5

Y1 - 2011/5

N2 - Despite significant advances in nonsurgical treatments of hepatocellular carcinoma, these approaches rarely result in cure. Surgery remains the mainstay of curative therapy for hepatocellular carcinoma. Liver transplantation, in particular, has emerged as one of the most beneficial therapeutic modalities. Questions remain, however, regarding hepatocellular carcinoma surveillance, the choice of surgical resection versus transplantation, the role of chemotherapy, optimal selection criteria for transplantation, and the role of ablative therapies to halt tumor progression and downsize tumors exceeding transplant criteria.

AB - Despite significant advances in nonsurgical treatments of hepatocellular carcinoma, these approaches rarely result in cure. Surgery remains the mainstay of curative therapy for hepatocellular carcinoma. Liver transplantation, in particular, has emerged as one of the most beneficial therapeutic modalities. Questions remain, however, regarding hepatocellular carcinoma surveillance, the choice of surgical resection versus transplantation, the role of chemotherapy, optimal selection criteria for transplantation, and the role of ablative therapies to halt tumor progression and downsize tumors exceeding transplant criteria.

KW - Cirrhosis

KW - Hepatocellular carcinoma

KW - Liver transplantation

KW - Organ allocation

UR - http://www.scopus.com/inward/record.url?scp=79959304232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959304232&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2011.03.005

DO - 10.1016/j.cld.2011.03.005

M3 - Article

C2 - 21689620

AN - SCOPUS:79959304232

VL - 15

SP - 385

EP - 393

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 2

ER -